Do you want to read an article? Please log in or register.
Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial
COPD
RECOMMENDED
Related content
RECOMMENDED
Further Publications
12-months follow-up of pulmonary tele-rehabilitation versus standard pulmonary rehabilitation: A multicentre randomised clinical trial in patients with severe COPD.
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Godtfredsen N, Frølich A, Bieler T, Beyer N, Kallemose T, Wilcke T, Østergaard L, Andreassen HF, Martinez G, Lavesen M, Hansen H
doi: 10.1016/j.rmed.2020.106129.
COMMENTED
COPD
Effects of downhill walking in pulmonary rehabilitation for patients with COPD: a randomised controlled trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1183/13993003.00639-2020.
RECOMMENDED
COPD
Digitalizing multidisciplinary pulmonary rehabilitation in COPD with a smartphone application: an international observational pilot study
Int J Chron Obstruct Pulmon Dis.
Rassouli F, Boutellier D, Duss J, Huber S, Brutsche MH
doi: 10.2147/COPD.S182880.
RECOMMENDED
COPD
Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax.
Pavitt MJ, Tanner RJ, Lewis A, Buttery S, Mehta B, Jefford H, Curtis KJ, Banya WAS, Husain S, Satkunam K, Shrikrishna D, Man W, Polkey MI, Hopkinson NS
doi: 10.1136/thoraxjnl-2019-214278.
RECOMMENDED
COPD
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Vogelmeier CF, Kerwin EM, Bjermer LH, Tombs L, Jones PW, Boucot IH, Naya IP, Lipson DA, Compton C, Barnes N, Maltais F
doi: 10.1177/1753466620968500
RECOMMENDED
COPD
Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated COPD Patients (CLAIM): A Double-Blind, Randomised, Crossover Trial
Am J Respir Crit Care Med.
Vogel-Claussen J, Schönfeld CO, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, Tillmann HC, Berschneider K, Hiltl S, Bauersachs J, Welte T, Hohlfeld JM
doi: 10.1164/rccm.
COMMENTED
Pulmonary Hypertension
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension
Eur Respir J.
Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Noordegraaf AV, Peacock AJ
doi: 10.1183/13993003.00332-2018.
RECOMMENDED
COPD
Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Patel S, Palmer MD, Nolan CM, Barker RE, Walsh JA, Wynne SC, Jones SE, Shannon H, Hopkinson NS, Kon SSC, Gao W, Maddocks M, Man WD
doi: 10.1136/thoraxjnl-2020-215281.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Further Publications
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G, REPLACE investigators.
doi: 10.1016/S2213-2600(20)30532-4